retatrutide clinical trial results weight loss π PHASE 3 RESULTS: BY THE NUMBERS Let's break down what the trials actually showed: SURMOUNT-1 (68 weeks): β’ Average loss: 24% of body weight β’ Participants Retatrutide Shows 28% Weight Loss
Description
It is a shift in mindset

Approved injection sites Three areas are standard for subcutaneous peptide injections: Abdomen: The most common site
The amount of weight lost with Semaglutide can vary for each individual

For some people, the thoughts are simply stronger and more persistent than for others

Cold Stop: Which Approach Works Better Abruptly stopping Ozempic typically produces sharper appetite rebound than a gradual dose reduction
